![A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity | Fluids and Barriers of the CNS | Full Text A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity | Fluids and Barriers of the CNS | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12987-020-00230-3/MediaObjects/12987_2020_230_Fig1_HTML.png)
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity | Fluids and Barriers of the CNS | Full Text
![Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/843953/843953_Thumb_400.jpg)
Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers
![Biomedicines | Free Full-Text | Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions Biomedicines | Free Full-Text | Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions](https://pub.mdpi-res.com/biomedicines/biomedicines-08-00389/article_deploy/html/images/biomedicines-08-00389-ag.png?1602323757)
Biomedicines | Free Full-Text | Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions
![Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41597-021-01054-y/MediaObjects/41597_2021_1054_Fig1_HTML.png)
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data
![Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-020-0804-9/MediaObjects/42003_2020_804_Fig1_HTML.png)
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease | Communications Biology
![A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-23687-8/MediaObjects/41467_2021_23687_Fig1_HTML.png)
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech | Nature Communications
![Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67448b2eb564ec8878d55caed12c24a35fdd40cc/3-Figure1-1.png)
Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology | Semantic Scholar
![Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs12276-019-0250-2/MediaObjects/12276_2019_250_Fig1_HTML.png)
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine
![Cancers | Free Full-Text | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue Cancers | Free Full-Text | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue](https://pub.mdpi-res.com/cancers/cancers-11-00469/article_deploy/html/images/cancers-11-00469-g001.png?1571326594)
Cancers | Free Full-Text | Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
![Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health: Trends in Molecular Medicine Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/8b241b8b-a8ac-4221-be72-3eaedab50e99/gr1_lrg.jpg)
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health: Trends in Molecular Medicine
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study | PLOS Medicine
![Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-020-00840-3/MediaObjects/41386_2020_840_Fig1_HTML.png)